See also this year's filing and all EDGAR filings for this company.
PDF Report 0001173281_2022_NeuBase_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001173281')"} |
Graph
Absolute values for 0001173281, NeuBase Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 54,928,634 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 2,463,882 |
| 3 | remainder_Assets | 6,775,077 |
| 4 | LiabilitiesCurrent | 4,194,224 |
| 5 | LiabilitiesNoncurrent | 5,794,096 |
| 6 | remainder_Liabilities | 109,500 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 12,202,217 |
| 9 | ResearchAndDevelopmentExpense | 11,475,201 |
| 10 | remainder_Expenses | 2,888,029 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,156,146 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 64,167,593 |
| 1 | Liabilities | 10,097,820 |
| 2 | Expenses | 26,565,447 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 54,069,773 |
| 5 | NetIncome | -25,409,301 |
| 6 | ComprehensiveNetIncome | -25,409,301 |
| 7 | BaseVar | 50,993,503 |
| 8 | EconomicCapitalRatio | 1.82 |
Edgar->Model Mapping
Feature Distribution
Change over Time
